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HumanCD1c isaprotein thatactivatesabTcells
by presenting self antigens, synthetic mannosyl
phosphodolichols, and mycobacterial manno-
syl phosphopolyketides. To determine which
molecular features of antigen structure confer
a T cell response, we measured activation by
structurally divergent Mycobacterium tubercu-
losis mannosyl-b1-phosphomycoketides and
synthetic analogs with either stereorandom or
stereospecific methyl branching patterns.
T cell responses required both a phosphate
and a b-linked mannose unit, and they showed
preference for C30–34 lipid units with methyl
branches in the S-configuration. Thus, T cell
responses were strongest for synthetic com-
pounds that mimicked the natural branched
lipids produced by mycobacterial polyketide
synthase 12. Incorporation of methylmalonate
to form branched lipids is a common bacterial
lipid-synthesis pathway that is absent in verte-
brates. Therefore, the preferential recognition
of branched lipids may represent a new lipid-
based pathogen-associated molecular pattern.
INTRODUCTION
Three related antigen presentation systems function to
display structurally diverse antigens to ab T cells: major
histocompatibility complex (MHC) class I, MHC class II,
and CD1. All three types of antigen presenting molecules
fold in three dimensions to form hollow antigen-binding
grooves. Whereas MHC proteins capture peptides and
glycopeptides for display to T cells, the grooves of CD1
proteins are larger and lined by hydrophobic amino acids
[1]; which makes them specialized to bind lipids (reviewed
in [2]). The CD1 system consists of five homologous iso-
forms in humans, CD1a, CD1b, CD1c, CD1d, and CD1e1232 Chemistry & Biology 14, 1232–1242, November 2007 ª20[3]. CD1e is an intracellular protein that functions to trans-
fer lipids [4, 5]. The other four human CD1 proteins are
expressed on the surface of antigen presenting cells
(APCs) and bind lipids within their grooves such that the
more hydrophilic elements of the antigens, such as carbo-
hydrates, peptides, and phosphoesters, protrude from the
groove to contact T cell receptors (TCRs) [6–9]. Crystal
structures show that CD1a, CD1b, and CD1d grooves dif-
fer in their overall size and shape [1, 10, 11]. CD1 isoforms
are differentially expressed on B cells, Langerhans cells,
and myeloid dendritic cells (DCs), and, in some cases,
multiple CD1 isoforms are expressed in the same APC
[12]. This suggests that multiple CD1 proteins function
together as a family, and that they use their structurally
divergent grooves to capture and present diverse classes
of self and foreign lipids to T cells. The structures of known
antigens are diverse and include molecules composed of
mycolate [13, 14], diacylglycerol [15–17], sphingolipid [7,
18–20], polyisoprenol [21], polyketide [22], fatty acyl [23,
24], and other lipid anchors [25]. These antigens have
been isolated from microbial pathogens, mammalian
cells, and synthetic sources, raising the question of how
T cells might discriminate among different classes of self
and foreign antigens.
In MHC systems, early observations that cells somehow
convert full-length proteins into recognizable forms
through cellular ‘‘antigen processing’’ have been tested
by genetic mapping of minimal peptide epitopes [26], elu-
tion of peptides from MHC proteins [27–29], synthesis of
peptide analogs, and crystallization of MHC-peptide com-
plexes [30–32]. Collectively, these studies have provided
chemically precise descriptions of the optimal size of an-
tigens for MHC class I (nonamer peptides) and MHC class
II (dodecamer peptides) [33, 34]. This basic information
has supported innumerable studies of epitope mapping
in autoimmune and infectious disease, subunit vaccine
design, and synthesis of partial agonists for T cells [35–
37]. With growing numbers of antigens identified in the
CD1 system, the search for chemical motifs that define
antigens presented by each type of CD1 protein is now
beginning. Unlike MHC-encoded antigen presenting mol-
ecules, the genes encoding CD1 proteins show low levels07 Elsevier Ltd All rights reserved
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dues located in the a1 and a2 domains of the CD1 heavy
chain, and form the structures that mediate antigen bind-
ing [38]. Therefore, the specificities of CD1 proteins for
lipids likely does not vary among individuals in a popula-
tion, but it likely does vary among each of the distinct
CD1 isoforms expressed on APCs. The precise shapes
and volumes of mouse CD1d (1650 A˚3) and human
CD1b (2200 A˚3), CD1a (1300 A˚3), and CD1d (1400 A˚3)
proteins have been determined from crystal structures
[1, 10, 11, 39]. This information, along with the discovery
of many types of lipid antigens that differ in the number,
size, and molecular composition of their lipid anchors,
provides two complementary approaches to answer basic
questions about possible chemical motifs that govern lipid
antigen presentation.
Chemical synthesis of antigenic lipids can address
these basic questions and can also be used to produce
analogs with desired immunological properties. The po-
tent agonist of CD1d-restricted NK T cells, a-galactosyl
ceramide, has been used to influence outcomes in a vari-
ety of animal models of autoimmune, infectious, allergic,
and neoplastic disease [40]. By producing a-galactosyl
ceramides with slightly altered structures, such as short-
ened or unsaturated alkyl chains, it has been possible to
influence the half-life of action and the balance of Th1-
Th2 cytokines produced by the responding cells [41–43].
Such altered lipid ligands can strongly influence the
outcomes of in vivo animal models of multiple sclerosis,
rheumatoid arthritis, and inflammatory bowel disease
[44–46] (and reviewed in [47]). Conversely, b-galactosyl
ceramide, a nonactivating ligand for CD1d, can suppress
CD1d-mediated activation of NK T cells [7, 48, 49].
Although a variety of self and foreign lipids for CD1a,
CD1b, and CD1c proteins have been identified [50],
most or all of the existing ligands show low potency (acti-
vating T cells in the micromolar range) or must be pains-
takingly purified in small amounts from bacteria. There-
fore, there is a good rationale to synthesize antigenic
lipids with higher yield in structurally varied forms that
may activate, partially activate, or deactivate T cells.
Among the human CD1 proteins, CD1c is the isoform for
which there is currently the least information relating to
its molecular mechanisms of presentation to T cells. CD1c
is abundantly expressed on thymocytes, myeloid DCs,
and marginal zone B cells (reviewed in [12]). CD1c influ-
ences immunoglobulin class switching in vitro and human
responses to M. tuberculosis infection in vivo [21, 51].
CD1c can directly activate both ab and gd T cells in the
absence of exogenous antigens, suggesting that it likely
presents self antigens to T cells in vitro [52–54] and ex vivo
[55]. However, the molecular structures of these self anti-
gens are unknown. CD1c is the only human antigen pre-
senting molecule that has not been crystallized to date.
Therefore, the only available information on the molecular
basis of lipid presentation comes from studies of the for-
eign glycophospholipid antigens that it presents, synthetic
mannosyl phosphodolichols (MPDs) and mannosyl-b1-
phosphomycoketides (MPMs) from M. tuberculosis andChemistry & Biology 14, 1232–1242M. avium [21]. The C30–34 alkyl chains in mycoketide anti-
gens have methyl branches at C4 (d-methyl) and at every
fourth carbon atom thereafter. This highly unusual
branched lipid is made by the alternating incorporation of
malonyl (C2) and methylmalonyl (C3) units by polyketide
synthase 12 (Pks12), an enzyme for which there is no
known homolog in non-mycobacterial cells [22].
Here, we investigate the specificity of this T cell re-
sponse by using natural [21] and synthetic mycoketide-
like compounds, including newly synthesized molecules
made according to synthesis schemes whose methods
have been previously described in detail [56, 57]. Aside
from their use as a tool for determining T cell specificity
for antigens, the total synthesis of highly antigenic
MPMs in high yield has been a longstanding priority in
this field for several reasons. MPMs comprise approxi-
mately one part per million (ppm) of the M. tuberculosis
cell wall. Its scarcity does not limit its ability to activate T
cells or influence antibiotic resistance in M. avium species
[21, 58]. However, the trace amounts of natural compound
available even from very large mycobacterial cultures
create a situation in which structural elucidation of natural
antigens was accomplished solely through sensitive colli-
sion-induced dissociation-mass spectrometry (CID-MS)
techniques. Thus, certain key elements of the structure
of the natural antigens, including the anomeric linkage of
the mannose unit and the position of the methyl branches,
were indirectly inferred from MS data. Therefore, direct
comparison of natural compounds with bona fide
synthetic standards more fully establishes the structure
of natural antigens. Last, structure-function analysis found
that the alkyl chain length, number, and stereochemistry
of the methyl branches of the lipid moiety strongly influ-
ence antigenicity. In all cases, synthetic MPMs that most
closely mimic the structure of natural mycobacterial
MPMs were found to be most potent. Because methyl
branching is common in bacterial fatty acyl and polyketide
systems and absent in mammalian fatty acids, identifica-
tion of methyl branching as a determinant of antigenic
potency now makes it a candidate lipid-based pathogen-
associated molecular pattern (PAMP) that may alert the
immune system to infection.
RESULTS
Synthetic Mycoketides with a Stereorandom
Branched Alkyl Chain Activate CD1c-Restricted
T Cells
To determine the structural basis of antigen recognition, we
prepared natural and synthetic MPM analogs. The biosyn-
thesis of the 4, 8, 12, 16, 20 pentamethyl pentasyl mycoke-
tide unit in mycobacteria involves the Pks12-mediated
condensation of C2 and C3 in a strictly alternating fashion
to build up the lipid in repeating C5 units [22]. The terminal
portion of the lipid unit consists of an alkyl chain of some-
what varying length (C5–9) that is thought to initiate the elon-
gation process (Figure 1A). Therefore, we used HPLC-
based methods to isolate individual molecular species of
natural M. tuberculosis b-mannosyl phosphomycoketides, November 2007 ª2007 Elsevier Ltd All rights reserved 1233
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increments in the terminal alkyl unit (Figure 1A). Second,
we synthesized b-mannosyl phosphomycoketide analogs
that varied in length by larger increments in the number
of repeating C5 units in the chain. This was accomplished
by using a method for stereospecifically coupling mannose
in b linkage with alkyl phosphate lipids made from polyiso-
prenols that had been saturated by using Adams’ catalyst
(platinum oxide) [56]. By altering the number of geranyl
units used, it was possible to make stereorandom MPM
analogs with C20 and C30 alkyl chains.
The low yields of mycobacterial antigens obtained to
date from natural sources have not been sufficient to
directly determine the stereochemistry of the five methyl
branches on the alkyl chain. However, because the 12
catalytic subunits of Pks12 are proposed to elongate in
5 cycles of the same reaction, all methyl branches are
likely to have the same stereochemistry. Further, the con-
figuration of methylmalonyl-CoA has been determined to
be S [59], and the carboxyl group of the methylmalonyl
unit is replaced by a distal primer side group in a decarbox-
ylative condensation reaction involving a mechanism that
likely does not alter the stereochemistry [22]. Therefore,1234 Chemistry & Biology 14, 1232–1242, November 2007 ª200the biosynthetic mechanism strongly suggests that the
mycoketide chain contains five S-stereocenters (all-S
mycoketide). Thus, the first synthetic approach recapitu-
lated the naturally recurring mycoketide unit insofar that
the methyl branches were inserted at the equivalent posi-
tions (4, 8, 12, 16, 20) of the main alkyl chain, but this
approach resulted in a mixture of compounds that have
either R- or S-stereochemistry at each of these chiral
centers (synthetic b-MPM [stereorandom], Figure 1B).
Because the stereochemistry of the methyl branches of
natural mycoketides had not been definitively determined,
this was considered an expeditious route to the prepara-
tion of immunologically active synthetic antigens.
All compounds were tested on an equimolar basis by
incubation with CD1c-expressing, monocyte-derived
DCs or transformed B lymphoblastoid cells (C1R) and by
measuring the antigen-dependent proliferation or IL-2
release by CD8-1, a human ab T cell line whose activation
requires CD1c expression by APCs ([54] and Figure S1,
see the Supplemental Data available with this article
online). Although synthetic stereorandom C30 b-MPM
stimulated an IL-2 response, the absolute potency
(Dosehalf maximal stimulation) of this compound was 20- to7 Elsevier Ltd All rights reserved
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(A–C) Titrated amounts of synthetic stereorandom C30 b-MPM and M.tb C32 b-MPM were incubated with CD1c-positive antigen presenting cells and
the CD8-1 T cell line for 24 hr, after which the levels of IL-2 released in the culture supernatant were determined by measuring 3H-thymidine incor-
poration by IL-2 dependent HT-2 cell line (A). Similar T cell activation assays were performed with the naturally occurring M.tb mannosyl phospho-
mycoketides with chain lengths of C30, C32 or C34 (B), and the synthetic stereorandom C20 and C30 b-MPM (C). The results are reported as mean ±
standard deviation of triplicate measurements. Similar results were obtained in two separate experiments.40-fold lower than that of M. tuberculosis C32 MPM. This
result suggests that either the small alterations in chain
length (C30 versus C32) or the methyl branching stereo-
chemistry strongly influenced recognition. Therefore, we
sought to separately evaluate the role of lipid length and
methyl branching in the T cell response.
Influence of Mycoketide Length
on T Cell Activation
Purified mycobacterial MPMs with mycoketide units of C30,
C32, or C34, which correspond to the natural range of lipid
lengths naturally produced by mycobacteria, stimulated
T cells with equivalent potency (Figures 1A and 2B). Prior
studies of mannosyl-b1-phosphodolichol (MPD) analogs
suggested that lipids in the range of C55–95 have little or
no ability to activate T cells compared to C35 analogs
[21]. Further, we found that a synthetic stereorandom C20
MPM was more than 1000-fold less potent than the analo-
gous compound C30 (Figure 2C). Thus, CD8-1 was most
potently activated by natural analogs whose chain lengths
correspond to those normally made by mycobacteria, as
compared to synthetic analogs that are substantially longer
or shorter. In addition, these results suggested that the 20-
to 40-fold difference in potency observed in the compari-
son between synthetic stereorandom C30 MPM and natural
M. tuberculosisC32 MPM (Figure 2A) wasnot accounted for
by the small difference in chain length. The difference in
potency was, therefore, more likely due to the differences
in the stereochemical orientation of the methyl branches.
Influence of Methyl Branching Patterns
and Stereochemistry on T Cell Activation
To directly address this question and to produce synthetic
compounds that might have the greatest potency for T cellChemistry & Biology 14, 1232–1242activation, we used a second approach involving the
stereospecific synthesis of MPM and analogs with each
methyl branch having S-configuration, corresponding to
that predicted to be found in mycobacterial antigens
(Figure 1C). This was possible by using a convergent strat-
egy in which enantiopure syn-isoprenoid building blocks
are assembled to yield lipid chains that have stereochemi-
cally defined methyl branches at all positions (all-S) [57].
Coupling of the C32 lipid chain alcohol to tetra-acetyl-
protected, a- or b-mannosyl phosphate afforded C32 a-
MPM (all-S) and C32 b-MPM (all-S) after deprotection. In
addition, three analogs of C32 b-MPM that contained the
same overall length of the main chain, but differed in the
number of methyl branches, were prepared. One analog
lacked all methyl groups on the alkyl chain (analog C,
Figure 3A; Supplemental Data), and two analogs lacked
all methyl groups except for the most proximal one at
position 4 and were prepared with either S- or R-configu-
ration (analogs A and B, respectively).
Consistent with prior high-titer T cell responses to bac-
terial extracts and preliminary analysis of a synthetic
compound [21, 57], quantitative analysis of natural and
synthetic antigens showed that both were extremely
potent in absolute terms, with half-maximal T cell activa-
tion seen at low-nanomolar concentrations (Figure 3B).
These foreign or synthetic antigens are at least 1000-
fold more potent than self lipid antigens like gangliosides
and sulfatides, which are recognized in the midmicromolar
range [18, 19, 60]. This is an absolute potency similar to
that of the most potent lipid antigens known in the CD1
system, such as a-galactosyl ceramides. The equipotency
of synthetic all-S C32 b-MPM and M. tuberculosis C32
MPM is consistent with the interpretation that they are
identical compounds., November 2007 ª2007 Elsevier Ltd All rights reserved 1235
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(A–C) Three analogs (A, B, and C) were prepared by coupling protected b-1-mannose phosphate to alkyl chains with or without a methyl group at
position 4. The complete description of the syntheses and analyses are included in the Supplemental Data. Titrated amounts of (B) synthetic enan-
tiopure all-S C32 b-MPM and M. tuberculosis C32 b-MPM or (C) synthetic C32 b-MPM analogs A, B, and C were incubated with CD1c-positive antigen
presenting cells and the CD8-1 T cell line for 24 hr, after which the levels of IL-2 released in the culture supernatant were determined by measuring
3H-thymidine incorporation by the IL-2-dependent HT-2 cell line. The results are reported as mean ± standard deviation of triplicate measurements
and are representative of results obtained in (B) two or (C) three separate experiments.1236 Chemistry & Biology 14, 1232–1242, November 2007 ª2007 Elsevier Ltd All rights reserved
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stereochemistry of the methyl branches showed that the
compound lacking four out of five methyl branches (ana-
log A) was 500-fold less potent (Figure 3C) than the fully
branched compound. The presence and stereochemistry
of this single methyl group seems to influence the T cell
response, because analog B, which is identical to analog
A except for its stereochemistry at the methyl branch,
showed an even further reduction of potency, similar to
an alkyl lipid lacking all methyl branches (analog C). It is
also notable that the least potent analogs are predicted
to be more water soluble than the most potent branched
compound, suggesting that the differences are not pri-
marily related to solubility in media. Overall, the reduced
potency of all three analogs indicates that the presence
of methyl branches on the lipid chain strongly influences
the capacity of the compound to stimulate the T cell
response.
Influence of the Mannose Glycosidic Linkage
on T Cell Activation
The synthesis of all-SC32 MPMs with both a- and b-anom-
erically linked mannose units provided authentic stan-
dards for definitively assessing the mannose linkage of
natural MPM antigens. Electrospray ionization-MS in the
negative mode showed that the M. tuberculosis com-
pound and both synthetic MPMs generated the expected
[M-H] ion at m/z 707.6, corresponding to C32 mannosyl
phosphomycoketide (Figure 4A, left). Low-energy CID-
MS of the 707.5 ion, however, revealed two fragmentation
patterns. The a-anomer of the synthetic MPM showed the
preferential loss of the mannose, resulting ina predominant
fragment ion of the alkyl phosphate (m/z 545.5), whereas
collision of the b-anomer resulted in a main fragment ion
of m/z 689.5, corresponding to a loss of H2O, and
a crossring cleavage product of m/z 587.5. Previous anal-
ysis of model compounds has suggested that fragments
equivalent to 587.5 are generated when the C2 hydroxyl
is cis to the C1 phosphate, as in the case of a b-1, but not
an a-1, mannosyl linkage [61]. The synthesis of authentic
a- and b-anomeric compounds provided standards for
comparison, which bear out this prediction. The identical
collisional MS spectra of the M. tuberculosis-isolated C32
MPM and the synthetic b-anomer of MPM confirm the
b linkage of the mannose in the natural compound. Testing
of these compounds, as well as phosphomycoketide and
mycoketide intermediates generated in the synthesis of
C30 MPM (stereorandom) (Figures 4B and 4C), confirms
that the presence of the phosphate and mannose units,
as well as their linkage in the b-configuration, is necessary
for the CD1c-mediated T cell response.
DISCUSSION
Here, we provide functional insight into how the fine
structure of an antigen controls a CD1c-restricted T cell
response. This has implications for the molecular mecha-
nism of T cell activation as well as for defining the types
of organisms and biosynthetic pathways that normallyChemistry & Biology 14, 1232–124produce such antigenic lipids. Other studies of glycolipids
presented by CD1b and CD1d have found that T cell
responses are not preserved after altering either the
number or linkage of carbohydrates [7, 19, 62], pointing
to carbohydrate linkage specificity as a general feature of
glycolipid antigen recognition. The recently solved ternary
CD1d-a-galactosylceramide-TCR crystal structure shows
precisely how the carbohydrate moiety influences the T
cell response based on its position at the interface of
CD1d and the TCR [9]. In this case, the galactosyl unit is
positioned at the opening of the groove so that the
a-anomeric linkage causes the hexose ring to lie roughly
parallel to the surface of CD1d and fits in a small cavity at
the CD1d-TCR interface. The b-linked anomer is predicted
to cause the ring to protrude outward from CD1d and
impede the approach of the TCR. The CD1c-restricted
T cell preference for the b-anomeric MPM, in contrast to
the a-anomeric glycosphingolipid, points to a difference
in the molecular mechanisms of carbohydrate positioning
in these CD1c and CD1d antigen presentation events.
The carbohydrate linkage has also been used to infer
the types of organisms that might produce antigenic
glycolipids. In the case of monoglycosyl ceramides, mam-
malian cells typically produce b-linked species, whereas
synthetic lipids, which recapitulate the structures of those
found inSphingomonas paucimobilis and related bacteria,
produce a-linked ceramides [20, 63]. The correlation of
a linkage with bacterial biosynthesis pathways led to the
more general speculation that the a-linked sugar is the
key chemical element that allows certain subsets of sphin-
golipids to be recognized as foreign by CD1d-restricted
NK T cells. This and prior studies identify 1-linked mannosyl
phospholipids as CD1c-presented antigens [21, 57]. Here,
we provide further evidence that natural mycobacterial
mannosyl phosphomycoketides contain b-anomerically
linked mannose units. Because candidate self antigens,
known as MPDs, have identical phosphomannose units,
the search for a chemical basis for recognizing
mycobacterial MPMs as foreign must consider aspects of
the fine structure of the lipid moieties of related com-
pounds.
It is notable that both known classes of antigens pre-
sented by CD1c, MPD, and MPM, have repeating methyl
branches [21, 22]. With one exception that contains both
straight-chain and branched lipids [23], all known antigens
presented by all other CD1 isoforms lack such branches,
raising the possibility that methyl branching represents
an isoform-specific motif for CD1c-presented antigens.
Definitive proof of this hypothesis requires further identifi-
cation of CD1c-presented antigens, as well as study of the
natural ligands eluting from CD1c proteins and crystal
structures of CD1c-lipid complexes. However, direct
evidence that methyl branches contribute to the T cell
activation event supports this hypothesis (Figure 3). A can-
didate mechanism for this effect has been proposed in
which the repeating methyl branches might function like
a ratchet to retain lipids within the groove [64], in contrast
to the known interaction of straight-chain lipids with the
slender, unbranched A0 pocket of CD1a [10, 65].2, November 2007 ª2007 Elsevier Ltd All rights reserved 1237
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(A) Electrospray ionization MS in the negative mode of M. tuberculosis C32 MPM and synthetic C32 a-MPM and C32 b-MPM yielded an expected
[M-H] ion at m/z 707.5 in all three samples. Prior studies [61] have shown that the through-ring cleavage product of m/z 587.5 is favored when
the substituents at C1 and C2 are cis, as in b-mannosyl phosphates. Low-energy collision-induced dissociation-mass spectrometry showed identical
fragmentation patterns of M. tuberculosis-isolated C32 MPM and the synthetic b-anomer, confirming the b linkage of the mannose in the natural
compound.
(B and C) Intermediates of the C30 b-MPM (stereorandom) synthesis, including (B) unmannosylated phosphomycoketide and mycoketide and (C) C32
mannosyl phosphomycoketide with a- or b-anomerically linked mannose, were tested for their capacity to induce IL-2 release by CD1c-restricted
T cells (CD8-1). The results are reported as mean ± standard deviation of triplicate measurements. Similar results were obtained in (B) two or (C) three
separate experiments.The synthetic analogs studied here bridge among the
natural structures found in three types of lipid anchors
for CD1-presented antigens: alkyl units (fatty acids, sphin-
gosines), polyisoprenol units (polyprenols, dolichols), and1238 Chemistry & Biology 14, 1232–1242, November 2007 ª20polyketide units (mycoketides, phthioceranic acids). All
known self lipid antigens in the CD1 system and almost ev-
ery nonterpenoid lipid in mammalian cells are composed
of unbranched alkyl chains in the range of C12–24 [50].07 Elsevier Ltd All rights reserved
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lipid motif that is a pathogen-associated molecular pattern
(PAMP) that allows for activation of CD1c-restricted T cells
in the setting of infection [66] in much the same way as the
Vg9Vd2 T cells preferentially recognize bacterial hydroxy-
methylbutenyl pyrophosphate compared to mammalian
isopentenyl pyrophosphates [67–70]. The two known bio-
synthetic mechanisms for producing methyl branches in-
volve polyketide synthases and polyisoprenol synthases.
Polyketide synthases are only known in nonmammalian
organisms, supporting the idea that these are intrinsically
foreign structures [71]. However, polyisoprenoid lipids are
made by all cellular organisms, and CD1c proteins can
present synthetic MPDs, when their length is C35 [21].
However, the C35 chain length is a synthetic construct,
and naturally occurring polyisoprenols in mammalian cells
are made as C90–100 dolichols or as C10–20 prenyl modifica-
tions of proteins, which fall outside the optimal C30–34
length reported here.
Thus, T cells showed specificity for the carbohydrate
linkage (b-anomer) as well as the structure of the lipid units
with the overall size (C30), number of methyl groups (5),
and their stereochemistry (S) corresponding to those
made naturally by a foreign enzyme present in disease-
causing species of mycobacteria. Whereas synthetic C32
b-mannosyl phosphomycoketide can potently activate
a specific T cell line, studies in polyclonal T cells from
healthy donors or M. tuberculosis-infected patients will
ultimately establish the capacity of this compound to
activate populations of CD1c-restricted T cells ex vivo.
Although the responses of any single T cell line may not
be representative of CD1c-restricted T cells in general,
the mycoketide moiety likely interacts with portions of
groove structures formed by invariant regions of the
a1-a2 superdomain and are therefore likely conserved in
human CD1c-mediated antigen presentation events.
SIGNIFICANCE
This detailed structure-function study of CD1c-pre-
sented antigens serves to frame a general hypothesis
about the structures of CD1-presented antigens in
which CD1c may selectively bind or retain foreign
lipids with unusual length (C30–34) and methyl branch-
ing, rather than the larger pool of unbranched, shorter
self lipid antigens. Thus, branched alkyl lipids of inter-
mediate length may be a lipidic pathogen-associated
molecular pattern recognized by CD1c. Further, the
direct comparison of natural MPMs with bona fide
standards with defined stereochemistry strongly sup-
ports prior speculations that these antigens are com-
posed of b-linked carbohydrates andmethyl branches
in the S-configuration; thus, this study now provides
a complete chemical identification of the natural
immunomodulatory lipids. Last, whereas a-galactosyl
ceramides have now been extensively studied in mice
[40, 72], high-potency ligands for the CD1 isoforms
lacking in mice but present in humans have not yet
been developed. CD1c is abundantly expressed onChemistry & Biology 14, 1232–1242humanmarginal-zone B cells, which play an important
role in the early stages of immune response [73].
Therefore, the synthesis of a mannosyl-b1-mycoke-
tide in good yield provides a highly potent reagent
for testing the functions of human CD1c-restricted
T cells ex vivo and for possible development as a com-
ponent of a subunit vaccine [74] or as an immunomod-
ulatory agent.
EXPERIMENTAL PROCEDURES
Natural Mycobacterial b-Mannosyl Phosphomycoketides
Mannosyl phosphomycoketides (MPMs) were purified from M. tuber-
culosis H37rv and M. avium by using refinements of previously
described methods [22]. Briefly, MPM was extracted from CHCl3/
CH3OH extracts of whole mycobacteria by using an open silica gel
column (Alltech) eluted sequentially with chloroform, acetone, and
methanol. Methanol-eluting fractions were further purified by using
one-dimensional preparative thin-layer chromatography (silica gel G
plate, Analtech, Inc.) with a solvent system of CHCl3:CH3OH:H2O:
NH4OH (60:35:7.2:0.8 v/v/v/v). The lipid fraction with T cell activation
activity was extracted with CHCl3:CH3OH (1:1) from the silica gel
and was subjected to further separation by HPLC with a monochrome
Diol column coupled on-line to a LCQ Advantage ion-trap mass spec-
trometer. To separate MPM homologs with different alkyl backbones,
reverse-phase HPLC with a Vydac C8 reverse-phase column was
used, and the compounds were eluted with isopropanol:methanol:-
acetonitrile:hexane:water (37:30:18:3:12, v/v/v/v/v) containing 6 mM
ammonium acetate. This method yielded peak to baseline separations
of C30 MPM (m/z 679.6), C32 MPM (m/z 707.6), and C34 MPM (m/z
735.6). In order to quantify trace amounts of recoverable HPLC-puri-
fied M. tuberculosis MPM by mass spectrometry, synthetic C20 MPM
was used as an internal standard. A total of 1 mM synthetic C20 MPM
(10 ml) and HPLC-purified M. tuberculosis MPM were mixed and
detected by electrospray mass spectrometry in the negative mode.
The concentration of M. tuberculosis MPM was determined by com-
paring the peak intensities of natural homologs of MPM (C32 MPM,
m/z 707.5; plus trace amounts of C30 MPM, m/z 679.5 and C31
MPM, m/z 693.5) to the intensity of synthetic C20 MPM (m/z 539.5).
The same method was used to quantify the synthetic C32 a-MPM
and C32 b-MPM that were used for the comparative assays.
Synthesis of b-Mannosyl Phosphomycoketide Analogs
The detailed description of the synthesis of the two lead compounds
analyzed here, stereorandom C30 b-mannosyl phosphomycoketide
(b-MPM) and the all-S a- and b-C32 MPM, has previously been
described [56, 57]. Full characterization of these compounds, includ-
ing the confirmation of the anomeric linkage of the mannose by 1H-,
13C-, and 31P-NMR and ESI-MS, is included in the Supplemental
Data. In the b-anomer, there is a Nuclear Overhauser Effect (NOE)
between the anomeric H and H3 and H5 that is absent in the a-anomer.
Additional support was given by comparison of the anomeric 1J CH
coupling constants of both anomers (a: 169 Hz; b: 159 Hz), and by a
distinct chemical shift in 1H-NMR between anomeric protons of both
compounds (a: 5.38 ppm; b: 5.07 ppm). The synthesis of analogs A
and B was carried out by using a general strategy that is similar to
that published for C32 b-MPM (all-S) [57]. This method comprised a
catalytic asymmetric conjugate addition of methylmagnesium bromide
to 3 (Figure 3A) by using a CuBr/(R,S)-Josiphos catalyst for analog
A and its enantiomer, CuBr/(S,R)-Josiphos, for analog B. This af-
forded building block 4 in 93% enantiomeric excess and of known
absolute configuration [58], which was subsequently converted into
6 by reduction and tosylation. Copper-mediated crosscoupling with
BrMg(CH2)20CH3 for analogs A and B gave the corresponding pro-
tected alkyl alcohols (Figure 3A, 8 for analog A). Deprotection, fol-
lowed by coupling to tetra-acetyl-protected b-1-mannose phosphate,, November 2007 ª2007 Elsevier Ltd All rights reserved 1239
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log A) in good yield. These compounds were purified by column chro-
matography, fully characterized, and shown to be pure by thin-layer
chromatography; 1H-, 13C-, and 31P-NMR; and ESI-MS. Final depro-
tection with Et3N in MeOH/CH2Cl2 gave the required MPM analogs
with a single methyl branch in the R- or S-configuration at position 4.
To prepare analog C, containing a straight-chain alkyl group, nona-
diol was monobenzylated and monotosylated, followed by crosscou-
pling with octadecylmagnesium bromide, leading to HO(CH2)26CH3
after debenzylation. Subsequent coupling with tetra-acetyl-protected
b-1-mannose phosphate and, finally, deprotection led to C. The struc-
ture and purity of the final compounds were determined by ESI-MS. A
detailed description of the syntheses of the b-MPM analogs, including
characterization with NMR and ESI-MS, is included in the Supplemen-
tal Data.
Cellular Assays
Monocyte-derived, CD1c-expressing APCs were prepared from
human PBMC by centrifugation over Ficoll-Hypaque, adherence to
plastic, and treatment with 300 IU/ml granulocyte/monocyte –col-
ony-stimulating factor and 200 IU/ml IL-4 for 72 hr, followed by g-irra-
diation (5000 rad). APC lines were generated from C1R lymphoblastoid
cells and k562 cells by stable transfection with vectors containing
cDNA encoding human CD1a, CD1b, CD1c, or CD1d heavy chains
(C1R transfected with vector pSRa-NEO, k562 transfected with vector
pcDNA3.1). A CD1c-restricted, mannosyl phosphomycoketide-reac-
tive T cell line (CD8-1) [6, 75] was tested for IL-2 release by using the
HT-2 bioassay. Briefly, 53 104 CD8-1 T cells and 53 104 g-irradiated
APCs were incubated in 200 ml T cell media containing serial dilutions
of lipids antigen for 24 hr, after which 50 ml supernatant was analyzed
for IL-2 release [62]. Supernatant was added to wells containing 100 ml
media and 104 IL-2-dependent HT2 cells, which were cultured for 24 hr
before 1 mCi 3H-thymidine was added for an additional 6 hr of culture,
followed by harvesting and counting of b emissions. Assays were
performed in triplicate and reported as the mean ± standard deviation.
Supplemental Data
Supplemental Data include data showing CD1c dependence of the
CD8-1 T cell line and detailed procedures for synthesis of the MPM
analogs and are available at http://www.chembiol.com/cgi/content/
full/14/11/1232/DC1/.
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